Pierre Fabre Pharma AG
- A12 - Suplementos minerales
- SELENASE PERORAL oral solution 100 µg/2 ml
- SELENASE PERORAL oral solution 500 µg/10 ml
- B03 - Preparados antianémicos
- GYNO-TARDYFERON prolonged-release tablet 80 mg+350 µg
- TARDYFERON prolonged-release tablet 80 mg
- B05 - Sustitutos de sangre y soluciones para perfusión
- SELENASE PRO INJECTIONE solution for injection 100 µg/2 ml
- SELENASE PRO INJECTIONE solution for injection 500 µg/10 ml
- D02 - Emolientes y protectores
- DEXERYL cream
- ONYSTER cutaneous emulsion 40%
- D07 - Preparados dermatológicos con corticosteroides
- CLARELUX cutaneous foam 500 µg/g
- D10 - Preparados contra el acné
- CURAKNE capsule, soft 10 mg
- CURAKNE capsule, soft 20 mg
- CURAKNE capsule, soft 40 mg
- CURAKNE capsule, soft 5 mg
- D11 - Otros preparados dermatológicos
- ALOPEXY cutaneous spray, solution 2%
- ALOPEXY cutaneous spray, solution 5%
- EKTOSELEN shampoo
- TAKROZEM ointment 1 mg/g
- G04 - Urológicos
- PERMIXON capsule, hard 160 mg
- L01 - Antineoplásicos
- BRAFTOVI capsule, hard 50 mg
- BRAFTOVI capsule, hard 75 mg
- EBVALLO dispersion 28 to 73 M.cells/ml
- MEKTOVI film-coated tablet 15 mg
- NAVELBINE capsule, soft 20 mg
- NAVELBINE capsule, soft 30 mg
- NAVELBINE concentrate for solution for infusion 10 mg/ml
- NAVELBINE concentrate for solution for infusion 50 mg/5 ml
- TOLAK cream 4%
- M01 - Antiinflamatorios y antirreumáticos
- STRUCTUM capsule, hard 500 mg
- N01 - Anestésicos
- ANESDERM cream 5%